scholarly article | Q13442814 |
P50 | author | Shibabrata Mukherjee | Q86867893 |
P2093 | author name string | Susmita Ghosh | |
Nilay K Das | |||
Mitali Chatterjee | |||
Joyashree N Barbhuiya | |||
Debanjan Mukhopadhyay | |||
P2860 | cites work | Direct association of adenosine deaminase with a T cell activation antigen, CD26 | Q24322080 |
Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis | Q24633365 | ||
IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani | Q24658015 | ||
Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling | Q28189055 | ||
Enhanced lesional Foxp3 expression and peripheral anergic lymphocytes indicate a role for regulatory T cells in Indian post-kala-azar dermal leishmaniasis | Q28268702 | ||
Targeting dipeptidyl peptidase IV (CD26) suppresses autoimmune encephalomyelitis and up-regulates TGF-beta 1 secretion in vivo | Q31838727 | ||
CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. | Q33892260 | ||
Foxp3 and IL-10 expression correlates with parasite burden in lesional tissues of post kala azar dermal leishmaniasis (PKDL) patients | Q33927377 | ||
CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. | Q33947051 | ||
Analysis of localized immune responses reveals presence of Th17 and Treg cells in cutaneous leishmaniasis due to Leishmania tropica | Q35051071 | ||
IL-10 neutralization promotes parasite clearance in splenic aspirate cells from patients with visceral leishmaniasis | Q35188445 | ||
CD8 T cell exhaustion in human visceral leishmaniasis | Q37416246 | ||
Dipeptidyl peptidase in autoimmune pathophysiology. | Q37853155 | ||
Leishmaniasis: complexity at the host-pathogen interface. | Q37900121 | ||
Post kala-azar dermal leishmaniasis: an unresolved mystery | Q38175646 | ||
A male preponderance in patients with Indian post kala-azar dermal leishmaniasis is associated with increased circulating levels of testosterone | Q39279491 | ||
A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis | Q39412297 | ||
Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation | Q44606441 | ||
Decreased presence of Langerhans cells is a critical determinant for Indian Post kala-azar dermal leishmaniasis | Q46483508 | ||
Impaired expression of CD26 compromises T-cell recruitment in human visceral leishmaniasis. | Q50946650 | ||
Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes | Q68318310 | ||
A novel pathway of human T cell activation via a 103 kD T cell activation antigen | Q70322731 | ||
CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response | Q77378978 | ||
Decreased dipeptidyl peptidase IV enzyme activity of plasma soluble CD26 and its inverse correlation with HIV-1 RNA in HIV-1 infected individuals | Q77886591 | ||
Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis | Q81180513 | ||
CD26 expression on CD4+T cells in patients with cutaneous leishmaniasis | Q81224632 | ||
Multiple pathways of amino terminal processing produce two truncated variants of RANTES/CCL5 | Q81795672 | ||
High concentration of adenosine in human visceral leishmaniasis despite increased ADA and decreased CD73 | Q84507171 | ||
Miltefosine effectively modulates the cytokine milieu in Indian post kala-azar dermal leishmaniasis | Q84967561 | ||
P433 | issue | 1 | |
P921 | main subject | India | Q668 |
visceral leishmaniasis | Q2046113 | ||
P304 | page(s) | 85-94 | |
P577 | publication date | 2015-12-07 | |
P1433 | published in | Journal of Clinical Immunology | Q6294961 |
P1476 | title | Decreased Frequency and Secretion of CD26 Promotes Disease Progression in Indian Post Kala-azar Dermal Leishmaniasis | |
P478 | volume | 36 |
Q33724960 | A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: First-in-human trial of ChAd63-KH. |
Q61444559 | Impaired activation of lesional CD8 T-cells is associated with enhanced expression of Programmed Death-1 in Indian Post Kala-azar Dermal Leishmaniasis |
Q26749758 | Possibilities and challenges for developing a successful vaccine for leishmaniasis |
Search more.